Our short-term strategy is to provide a series of histopathological analysis modules, particularly in breast pathology, that will enable pathologists to improve the quality and performance of their activity. In the medium term we will develop a series of cytopathological analysis modules to enable cytologists and cytologists to improve the analysis of their samples in the context of large-scale cancer screening.
Our medium-term strategy is to provide a series of modules to enable cytologists to improve the scalability of their work. This allows for better care at a lower cost.
Our long-term strategy is to develop prognostic tools that integrate computer pathology with electronic health records, genomics and other clinical data to provide clinicians with layers of information to better optimize patient care.